Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ACVA
|
Robert P Goodman |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Nov 25
2024 |
|
INOD
|
Louise C Forlenza
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 32.58% |
$180,400
$45.1 p/Share
|
Nov 25
2024 |
|
INOD
|
Louise C Forlenza
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.0% |
$45,540
$45.54 p/Share
|
Nov 25
2024 |
|
APPF
|
Maurice J Duca |
SELL
Open market or private sale
|
Direct | 2,577 Reduced 47.27% |
$643,167
$249.58 p/Share
|
Nov 25
2024 |
|
INOD
|
Jack Abuhoff
CEO and President |
SELL
Open market or private sale
|
Direct | 187,099 Reduced 13.6% |
$8,606,554
$46.0 p/Share
|
Nov 25
2024 |
|
INOD
|
Jack Abuhoff
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 187,099 Added 11.97% |
$200,195
$1.07 p/Share
|
Nov 25
2024 |
|
ROK
|
Cyril Perducat
SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 21.6% |
$300,000
$300.0 p/Share
|
Nov 25
2024 |
|
ROK
|
Blake D. Moret
President and CEO |
SELL
Open market or private sale
|
Indirect | 26,700 Reduced 0.0% |
$7,960,071
$298.13 p/Share
|
Nov 25
2024 |
|
ROK
|
Blake D. Moret
President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 26,700 Added 0.0% |
$2,778,936
$104.08 p/Share
|
Nov 25
2024 |
|
ROK
|
Matheus De A G Viera Bulho
SVP Software and Control |
SELL
Open market or private sale
|
Direct | 350 Reduced 29.39% |
$105,000
$300.0 p/Share
|
Nov 25
2024 |
|
RGTI
|
Michael S. Clifton |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 8.69% |
$375,000
$3.0 p/Share
|
Nov 25
2024 |
|
BTCS
|
Melanie Pump
Director |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 36.22% |
$76,780
$3.49 p/Share
|
Nov 25
2024 |
|
CPSS
|
William B Roberts
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.32% |
$106,400
$10.64 p/Share
|
Nov 25
2024 |
|
RNGR
|
Brett T. Agee |
SELL
Open market or private sale
|
Indirect | 91,488 Reduced 0.0% |
$1,526,019
$16.68 p/Share
|
Nov 25
2024 |
|
CRM
|
Sabastian Niles
President and CLO |
SELL
Open market or private sale
|
Direct | 931 Reduced 37.39% |
$319,156
$342.81 p/Share
|
Nov 25
2024 |
|
CRM
|
Miguel Milano
President and CRO |
SELL
Open market or private sale
|
Direct | 719 Reduced 13.37% |
$246,480
$342.81 p/Share
|
Nov 25
2024 |
|
JCI
|
George Oliver
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 10,304 Reduced 0.88% |
$866,978
$84.14 p/Share
|
Nov 25
2024 |
|
JCI
|
George Oliver
Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,304 Added 0.87% |
$358,785
$34.82 p/Share
|
Nov 25
2024 |
|
LAD
|
Bryan B Deboer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,742 Reduced 3.72% |
$2,696,800
$400.0 p/Share
|
Nov 25
2024 |
|
SHOO
|
Peter Allan Davis
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 6.06% |
$22,695
$45.39 p/Share
|
Nov 25
2024 |
|
FLL
|
Lewis A. Fanger
Sr. VP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 3,856 Reduced 1.49% |
$19,318
$5.01 p/Share
|
Nov 25
2024 |
|
FLL
|
Lewis A. Fanger
Sr. VP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,856 Added 1.47% |
$5,282
$1.37 p/Share
|
Nov 25
2024 |
|
NXST
|
Brett Jenkins |
SELL
Open market or private sale
|
Direct | 4,331 Reduced 14.5% |
$739,041
$170.64 p/Share
|
Nov 25
2024 |
|
AFRM
|
Robert O'Hare
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 79,039 Reduced 100.0% |
$5,533,520
$70.01 p/Share
|
Nov 25
2024 |
|
AFRM
|
Robert O'Hare
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 79,039 Added 50.0% |
$3,872,911
$49.0 p/Share
|
Nov 25
2024 |
|
CFLT
|
Matthew Craig Miller
Director |
SELL
Open market or private sale
|
Indirect | 157,890 Reduced 0.0% |
$5,191,423
$32.88 p/Share
|
Nov 25
2024 |
|
CFLT
|
Matthew Craig Miller
Director |
BUY
Conversion of derivative security
|
Indirect | 157,890 Added 0.0% |
-
|
Nov 25
2024 |
|
RDVT
|
James Patrick Reilly
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.54% |
$372,500
$37.25 p/Share
|
Nov 25
2024 |
|
BLKB
|
Michael P Gianoni
President and CEO |
SELL
Open market or private sale
|
Direct | 9,479 Reduced 2.68% |
$835,384
$88.13 p/Share
|
Nov 25
2024 |
|
RDVT
|
Daniel Mac Lachlan
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.44% |
$372,500
$37.25 p/Share
|
Nov 25
2024 |
|
RDVT
|
Derek Dubner
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.65% |
$372,500
$37.25 p/Share
|
Nov 25
2024 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 0.12% |
$720,500
$14.41 p/Share
|
Nov 25
2024 |
|
RDVT
|
Jeffrey Alan Dell
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.2% |
$372,500
$37.25 p/Share
|
Nov 25
2024 |
|
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct | 4,186 Added 21.83% |
$83,678
$19.99 p/Share
|
Nov 25
2024 |
|
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct | 14,010 Reduced 93.47% |
$1,250,672
$89.27 p/Share
|
Nov 25
2024 |
|
FLR
|
Mark E Fields
GROUP PRESIDENT |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 25.38% |
$2,842,000
$56.84 p/Share
|
Nov 25
2024 |
|
CON
|
Robert A Ortenzio |
BUY
Other acquisition or disposition
|
Indirect | 4,781,340 Added 0.0% |
-
|
Nov 25
2024 |
|
CON
|
Robert A Ortenzio |
BUY
Other acquisition or disposition
|
Direct | 5,513,054 Added 50.0% |
-
|
Nov 25
2024 |
|
CON
|
Michael D. Rhine |
BUY
Other acquisition or disposition
|
Direct | 98 Added 50.0% |
-
|
Nov 25
2024 |
|
CON
|
Daniel Thomas |
BUY
Other acquisition or disposition
|
Direct | 53,260 Added 50.0% |
-
|
Nov 25
2024 |
|
ZION
|
Jason D. Arbuckle
SVP - Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 314 Reduced 15.82% |
$19,562
$62.3 p/Share
|
Nov 25
2024 |
|
ZION
|
Jason D. Arbuckle
SVP - Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 393 Added 18.46% |
$19,956
$50.78 p/Share
|
Nov 25
2024 |
|
SHBI
|
Konrad Wayson
Director |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 0.0% |
$50,820
$16.94 p/Share
|
Nov 25
2024 |
|
SOUN
|
Eric R. Ball |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 21.29% |
$240,899
$8.03 p/Share
|
Nov 25
2024 |
|
CON
|
Select Medical Corp |
SELL
Other acquisition or disposition
|
Direct | 104,093,503 Reduced 100.0% |
-
|
Nov 25
2024 |
|
CON
|
William Keith Newton
Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct | 32,831 Added 50.0% |
-
|
Nov 25
2024 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.0% |
$13,500
$6.75 p/Share
|
Nov 25
2024 |
|
IBCP
|
Larry R Daniel Jr
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,851 Reduced 15.63% |
$150,766
$39.15 p/Share
|
Nov 25
2024 |
|
TREX
|
Jacob T. Rudolph
SVP, CHRO |
SELL
Open market or private sale
|
Direct | 1,372 Reduced 5.31% |
$107,125
$78.08 p/Share
|
Nov 25
2024 |
|
INBP
|
Christina Kay
Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 55,555 Added 4.01% |
$4,999
$0.09 p/Share
|
Nov 25
2024 |